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Abstract  
Smaug is a conserved translational repressor that recognizes specific RNA motifs in a large number of 
mRNAs, including nuclear transcripts that encode mitochondrial enzymes. Smaug orthologs have been shown 
to form membraneless organelles (MLOs) in several organisms and cell types. Using single-molecule FISH we 
show here that SDHB and UQCRC1 mRNAs associate with Smaug1 MLOs in the human cell line U2OS. 
Simultaneous loss of function of Smaug1 and Smaug2 affects both mitochondrial respiration and mitochondrial 
network morphology. Deletion of specific Smaug1 protein regions resulted in impaired MLO formation that 
correlates with mitochondrial defects. In addition, rotenone but not the respiratory chain uncoupling agent 
CCCP rapidly induces Smaug1 MLO dissolution. Finally, metformin elicits a similar effect on Smaug1 MLOs 
and provokes the release of bounded mRNAs. We propose that mitochondrial activity affects Smaug1 MLO 
dynamics, thus allowing for regulation of nuclear mRNAs that encode key mitochondrial proteins. 
 
Introduction   
Smaug orthologs bind transcripts that contain a variety of stem-loops termed Smaug recognition elements 
(SREs). Several unbiased screens in Drosophila allowed the identification of thousands of target mRNAs that 
are involved in widely diverse cellular processes (Amadei et al., 2015; Aviv et al., 2006; Baez & Boccaccio, 
2005; Cao et al., 2020; Chartier et al., 2015; Chen, Dumelie, et al., 2014; Eichhorn et al., 2016; Johnson & 
Donaldson, 2006; Laver et al., 2012; Nelson et al., 2004; Niu et al., 2017; Oberstrass et al., 2006; Pinder & 
Smibert, 2013; Rouget et al., 2010; Semotok et al., 2005; Semotok et al., 2008; She et al., 2017; Tadros et al., 
2007). Messenger RNA regulation by Smaug can involve translational repression and/or decay. Both insects 
and vertebrates Smaug forms membraneless organelles (MLOs) termed Smaug-foci or Smaug-bodies, which 
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contain repressed mRNAs. Smaug bodies were identified in mammalian neuroblasts, hippocampal dendrites, 
fly embryo and adult muscle, and are distinct from Processing Bodies (PBs), a well-known type of MLO that 
also contain repressed mRNAs (Amadei et al., 2015; Baez & Boccaccio, 2005; Baez et al., 2011; Chartier et 
al., 2015; Luchelli et al., 2015; Rouget et al., 2010; Sachdev et al., 2019). The molecular consequences of 
Smaug-body formation are incipiently described. Condensation of the yeast ortholog Vts1 facilitates the 
degradation of target mRNAs (Chakravarty et al., 2020), whereas mammalian Smaug1-body dissolution is 
linked to mRNA release and translational activation of dendritic mRNAs (Baez et al., 2011; Luchelli et al., 
2015). The formation of MLOs and related molecular condensates is thought to involve liquid-liquid phase 
separation (LLPS) processes driven by multiple protein-protein interactions, which remain unknown in the case 
of Smaug  (Courchaine et al., 2016; Guo & Shorter, 2015; Perez-Pepe et al., 2018; Sachdev et al., 2019; Van 
Treeck et al., 2018).  
The dysregulation of Smaug orthologs in different organisms and tissues leads to a wide diversity of 
phenotypes. Drosophila Smaug loss of function provokes embryo defects due to the abnormal expression of 
maternal mRNAs. In addition, fly Smaug binds numerous mRNAs that code glycolytic and mitochondrial 
enzymes (Tadros et al., 2007). The two mammalian paralogs termed Smaug1/Samd4A and Smaug2/Samd4B 
are involved in neuron differentiation, synapse plasticity and bone development (Amadei et al., 2015; Baez et 
al., 2011; Luchelli et al., 2015; Niu et al., 2017). Overexpression of Drosophila Smaug or of mammalian 
Smaug1 in muscular cells suppress myotonic dystrophy-1 (MD1) (de Haro et al., 2013), whereas independent 
work identified both Drosophila Smaug and mammalian Smaug1 as enhancers of a mitochondrial defect 
caused by aberrant mRNA polyadenylation and linked to oculopharyngeal muscular dystrophy (OPMD) 
(Chartier et al., 2015). Finally, a point mutation in murine Smaug1 generates a complex phenotype 
characterized by leanness, resistance to fat intake-induced obesity, reduced muscle and adipose tissue, and 
abnormal morphology of both myofibers and adipocytes (Chen, Holland, et al., 2014). Work in yeast showed 
that Vts1 is involved in nutrient sensing (Chakravarty et al., 2020; She et al., 2017) and thus, a connection 
between Smaug and the energetic metabolism appears conserved from yeast to animals.  
Here we show that mammalian Smaug1 MLOs interact with nuclear mRNAs that encode mitochondrial 
enzymes. Specifically, single molecule FISH revealed that succinate dehydrogenase subunit B (SDHB) and 
ubiquinol-cytochrome C reductase core protein 1 (UQCRC1) mRNAs associated with Smaug1-bodies. In 
addition, loss of function of Smaug1 and Smaug2 affected both mitochondrial respiration and mitochondrial 
network complexity. The phenotype was rescued by full-length Smaug1 but not by Smaug1 deletion mutants 
with defective MLO formation. Finally, exposure to metformin –a metabolism activator widely used for the 
treatment of type II diabetes– immediately induced Smaug1-MLO dissolution and mRNA release. Complex I 
inhibition by rotenone similarly induced Smaug1-body dissolution whereas strong uncoupling by exposure to 
CCCP elicited no effect. We speculate that the condensation of Smaug1 MLOs help the control of nuclear 
transcripts that encode mitochondrial proteins through the regulated release of mRNAs.   
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Results 
 
SDHB and UQCRC1 mRNAs associate to Smaug1 membraneless organelles 
Smaug orthologs are expressed in several mammalian cell lines (Fernandez-Alvarez et al., 2016) and as 
expected, we found that Smaug1 forms cytosolic puncta in U2OS cells (Figure 1A). Smaug1-bodies were 
present is most cells (70-80%, 5 independent experiments, N≥200 cells each) with highly variable numbers. 
Their size and distribution remind that of PBs, however Smaug1-bodies did not colocalize with PBs identified 
by DCP1A staining (Figure 1A) as previously reported in neurons (Baez et al., 2011). Finally, Smaug1-bodies 
dissolve upon exposure to cycloheximide, suggesting that they can release translation-competent mRNAs 
(Figure 1B). 
Transfected Smaug1-EYFP or Smaug1-V5 condense in cytosolic bodies (Baez & Boccaccio, 2005; Baez et al., 
2011) and here we confirmed that they were similar in size and distribution to endogenous bodies. Smaug1-
EYFP bodies exclude ribosomal subunits detected by FISH with specific probes for 18S rRNA, indicating that 
they are not stress granules (Supplementary file 1). In addition, Smaug1-bodies did not contain ubiquitin, a 
marker of protein aggregates (Supplementary file 1), and thus we conclude that transfection of Smaug1 is a 
reliable strategy for further studies. Next, we performed real time microscopy and found that Smaug1-EYFP 
bodies were highly dynamic and they sporadically fuse, a feature characteristic of MLOs (Figure 1C, Video1). 
Drosophila Smaug was shown to bind several nuclear transcripts that encode mitochondrial enzymes 
(Bruzzone et al., 2020; Chartier et al., 2015; Tadros et al., 2007) and among many other putative mammalian 
targets, we analyzed NADH:ubiquinone oxidoreductase subunit A10 (NDUFA10), succinate dehydrogenase 
subunit B (SDHB), and ubiquinol-cytochrome C reductase core protein 1 (UQCRC1) mRNAs. We transfected 
and pulled-down Smaug1 fused to a V5-SBP double tag and evaluated the co-purification of these transcripts 
by RT-PCR (Figure 1D). Both SDHB and UQCRC1 mRNAs were recovered in the V5-SBP-Smaug1 pull-down 
material whereas the control construct V5-SBP-MBP did not pull-down these transcripts. In contrast, we found 
that NDUFA10 mRNA was not significantly enriched and recovery values were close to those of PP1A mRNA 
(Figure 1D).  Finally, Smaug1 ΔEIII, a natural splicing variant that forms similar cytosolic bodies (Fernandez-
Alvarez et al., 2016) showed a similar profile. These results are comparable to observations reported in 
Drosophila, where SDHB mRNA is four-fold enriched in fly Smaug pull-downs and NDUFA10 mRNA is among 
the less-bounded transcripts (Chartier et al., 2015). 
 
Then, we used single-molecule FISH to simultaneously detect SDHB mRNA, UQCRC1 mRNA and Smaug1-
EYFP bodies (Figure 1E). We found that a fraction of Smaug1-bodies contains or contact SDHB or UQCRC1 
mRNA puncta. Random colocalization was estimated as described in Material and Methods and resulted lower 
in both cases (Figure 1F). The presence of SDHB and UQCRC1 mRNAs in a single Smaug1-EYFP-body was 
not mutually exclusive and on the contrary, we found that the co-occurrence of the two transcripts was slightly 
higher than that predicted as independent events (0.13 vs 0.33 x 0.23=0.08 in Figure 1F). In addition, we found 
that Smaug1-bodies are frequently in contact with mitochondria identified by TOM20 immunostaining or by 
MitoTracker™ Red CMXRos staining (Figure 1G-H). Frequency of contacts with the mitochondria was 
moderately higher than that calculated in randomized images obtained as previously described for 
purinosomes (58% SD=9, vs 43% SD=5, N=10) (French et al., 2016). 
 
Smaug1 and Smaug2 knockdown impairs mitochondrial respiration  
We have previously shown that transfected Smaug1 and Smaug2 form cytosolic bodies that colocalize 
(Fernandez-Alvarez et al., 2016) and we speculated that mammalian Smaug proteins may affect mitochondria 
activity. We investigated the effect of the double knockdown (KD) of Smaug1 and Smaug2, which were efficiently 
silenced by specific siRNAs (Figure 2A). 
We measured the respiratory capacity of intact or permeabilized cells using high-resolution respirometry as 
described in Materials and Methods. We found significant changes in permeabilized cells analyzed by the 
substrate-uncoupler-inhibitor-titration (SUIT)-RP2 protocol (Doerrier et al., 2018) (Figure 2B) while no effects 
were observed in intact cells (Supplementary file 2). SUIT-RP2 allows to measure the F-pathway, the electron 
transport capacity, and the maximum oxidative phosphorylation (OXPHOS) by sequential addition of a number 
of substrates (see Methods). We found that routine endogenous respiration –which depends on intracellular 
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substrates– remained unchanged upon Smaug1+2 double KD, in accordance with the lack of effect observed 
in intact cells. In contrast, oxygen flux through fatty acid oxidation was reduced upon Smaug1 and Smaug2 
double KD (Figure 2B). A moderate reduction in oxygen flow was observed after activation of the N-pathway 
with malate (F(N)); the effect was more significant in the presence of malate, pyruvate and glutamate 
(FN(PGM)), and stronger upon the addition of succinate (FNS), suggesting defective complex I and II activities. 
Oxygen flow increased significantly in both control and KD cells after addition of glycerophosphate, indicating 
that glycerophosphate dehydrogenase shuttle (FNSGp) is functional in both cases, with almost normal 
maximum respiratory capacity and oxygen flow after inhibition of complex I (FNSGpe; SGpe). Finally, complex 
IV activity was not affected by Smaug1+2 double KD (siNT, 168 and siSmaug1+2, 164 pmol/s*mill 
cells*mtDNA, see methods).  
Altogether, these observations indicate decreased succinate-activated respiration upon Smaug1 and Smaug2 
double KD. In addition, we studied the effect of Smaug1+2 KD on mitochondrial membrane potential by JC-1 
staining followed by flow cytometry or confocal analysis. Cells treated with the strong depolarized agent 
carbonyl cyanide 3-chlorophenylhydrazone (CCCP) were analyzed in parallel. We found that depletion of 
Smaug1+2 did not significantly affect mitochondrial membrane potential (Figure 2C, D).  
 
 
Mitochondrial network disruption upon Smaug1 and Smaug2 knockdown 
Collectively, the above observations indicate that Smaug1+2 KD affects OXPHOS activity without provoking 
serious mitochondrial damage. We were interested in investigating the relevance of Smaug MLOs 
condensation to mitochondrial physiology. MLOs are typically assessed by microscopy and thus, we seek for 
mitochondrial phenotypes compatible with single-cell imaging. The mitochondrial network is dynamically 
regulated in connection with mitochondrial respiration changes and we analyzed its overall distribution by 
TOM20 staining (Figure 3). We classified the cells in two groups as short or elongated branched mitochondria 
and found that Smaug1 or Smaug2 KD significantly reduced the complexity of the mitochondrial network 
(Figure 3A). In five independent experiments, we found that 50 to 80 % of the control cells showed elongated 
mitochondria, and this number was reduced to 20-40% upon Smaug1 and Smaug2 double KD. Single KD of 
either Smaug1 or Smaug2 elicited a statistically significant effect yet not as strong as double KD (Figure 3B). 
Mitochondria were also analyzed by staining live cells with MitoTracker™ Red CMXRos and similar results 
were obtained (Supplementary file 3). The mitochondrial DNA content relative to the nuclear DNA content 
evaluated by qPCR of the mitochondrial gene for cytochrome C oxidase 2 and of the nuclear gene for 
succinate dehydrogenase subunit A yielded similar values in all conditions (siNT 1±0.3; siSmaug1, 1.1±0.3; 
siSmaug2 0.9±0.1; siSmaug1+siSmaug2 1.1±0.3), indicating that mitochondrial mass was not affected. 
The mitochondrial network morphology depends on the balance between fusion and fission and we analyzed 
changes in molecular markers of both processes. Mitochondrial fusion requires Opa1 mitochondrial dynamin 
like GTPase (Opa1), mitofusin 1 (Mfn1) and mitofusin 2 (Mfn2). Reduced fusion is linked to changes in Opa1 
protein cleavage and lower mitofusins levels. We found that both Opa1 and Mfn2 remained unaltered upon 
Smaug1 and Smaug2 double KD (Figure 3C). In contrast and as expected, CCCP elicited a strong response. 
Levels of Opa1 L fragment relative to S fragment levels were reduced, Mfn2 levels were downregulated, and all 
this correlated with decreased membrane potential (Figure 2D-E) and strong mitochondrial network 
fragmentation (Figure 3C) (Toyama et al., 2016). In addition, Opa1 and Mfn2 remained unaltered upon 
exposure to rotenone, which inhibits Complex I thus significantly triggering mitochondrial network fragmentation 
(Figure 3C,(Toyama et al., 2016). 
To further asses the integrity of the fusion machinery, we assessed a specific response termed stress-induced 
mitochondrial hyperfusion (SIMH) –which depends on Opa1 and Mfn1–, as previously described (Ehses et al., 
2009; Tondera et al., 2009); see Methods). We found that SIMH was not altered upon Smaug1+2 KD. The 
fraction of siRNA NT-treated cells that showed elongated mitochondria increased from 50% to 77% upon SIMH 
induction. Smaug1+2 KD cells also responded significantly and the proportion of cells with elongated 
mitochondria increased from 21% to 74% after SIMH induction (Figure 3D). Collectively, these observations 
indicate that the mitochondria fusion machinery is fully functional in Smaug1+2 KD cells. 
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Mitochondrial fission is actively directed by recruitment of dynamin 1 like (DRP1) to the mitochondrial surface 
(Hoppins et al., 2007; Pitts et al., 1999) and we found that the number of DRP1 puncta recruited to mitochondria 
upon Smaug1+2 KD doubled the basal levels (4 vs 9 puncta per 10µm; Figure 3E). Altogether with the above 
results, these observations suggest that Smaug1+2 double KD activate mitochondrial fission likely as a 
consequence of defective mitochondrial function. Then, we used the mitochondrial network complexity as a 
read-out to further investigate the relevance of Smaug MLO formation.  
First, we analyzed whether the mitochondrial phenotype provoked by Smaug1 and Smaug2 double KD is 
efficiently rescued by transfection of Smaug1 (Figure 4). We found that this is the case and in addition, the 
splicing variant ΔEIII, which has similar RNA binding and repression capacity (Figure 1 and(Fernandez-Alvarez 
et al., 2016), also rescued the mitochondrial phenotype (Figure 4). Altogether, these observations suggest that 
the three mammalian Smaug isoforms reported to date, Smaug1; Smaug1 ΔEIII and Smaug2 play a rather 
redundant role.  
Smaug’s main function is to control mRNAs and we investigated the effect of a Smaug1 construct lacking the 
SAM domain and downstream region (termed ΔSAM), which are required for RNA binding (Aviv et al., 2003; 
Baez et al., 2011; Green et al., 2003; Johnson & Donaldson, 2006; Oberstrass et al., 2006). In three 
independent experiments, where more than 400 cells were analyzed for each construct, we found that deletion 
of the domain involved in RNA binding abrogates the rescue of the phenotype (Figure 4), strongly suggesting 
that mRNA regulation by Smaug1 is key to mitochondrial physiology.  
 
Condensation-defective Smaug1 mutants affect mitochondria  
We aimed to investigate the relevance of Smaug1 MLOs condensation. First, we generated Smaug1 deletion 
mutants with defective body formation. Then, we used these tools as described in the next section to 
investigate the consequences of the lack of Smaug1-bodies on the mitochondrial network. 
The domain organization of mammalian Smaug1 is depicted in figure 5A. Besides the SAM domain, 
mammalian Smaug orthologs include two different protein regions termed Smaug Similarity Region 1 (SSR1) 
and Smaug Similarity Region 2 (SSR2), which are conserved in flies. The yeast ortholog Vts1p includes only 
SSR1, which was shown to dimerize in vitro (Tang et al., 2007). We conducted transient-transfection 
experiments with the deletion constructs depicted in Figure 5A to analyze the formation of cytosolic 
condensates (Figure 5B-D). Similar expression levels were confirmed by immunoblot (Figure 5B). We found 
that deletion of the amino terminal region including SSR1 and SSR2 abrogates Smaug1-body formation. The 
ΔSSR1/2 fragment was always uniformly distributed in the cytosol in U2OS cells either fused to ECFP, V5 or 
V5-SBP (Figure 5C-D), as well as in HeLa and Cos-7 cells (data not shown). The SSR1-SSR2 fragment 
(SSR1/2) was required but was not sufficient to phase-separate as it always showed a uniform distribution 
(Figure 5C). Additionally, a construct that lacks the first 53 amino acids and termed ΔSSR1 was not able to 
form cytosolic bodies (Figure 5C-D). Finally, the splicing variant ΔEIII also formed cytosolic bodies (Figure 5C-
D) as reported before (Fernandez-Alvarez et al., 2016). 
We next evaluated the recruitment of specific Smaug1 protein regions to the bodies formed by the full-length 
molecule. We co-transfected specific ECFP-tagged Smaug1 fragments with full length Smaug1 tagged with 
EYFP and measured the intensity of the ECFP tag inside and outside the Smaug1-EYFP bodies (Figure 6A). 
We found that SSR1/2-ECFP and the complementary construct ΔSSR1/2-ECFP, both of which remained 
uniformly distributed when expressed alone (Figure 5C), were efficiently recruited to the Smaug1-EYFP bodies. 
In contrast, the construct termed SAM-ECFP, which includes the SAM domain and 47 amino acids 
downstream, behaved similar to ECFP, both remained uniform and were not recruited to the Smaug1-EYFP 
bodies (Figure 6A). 
In parallel, we analysed physical interactions between these specific Smaug1 protein regions by pull-down 
assays. We co-expressed the Smaug1 fragments tagged with ECFP together with a full-length Smaug1 fused 
to a V5-SBP double tag. As expected, the pull-down of V5-SBP-Smaug1 efficiently recovered Smaug1-ECFP 
and did not significantly recover ECFP, which we chose as a negative control (Figure 6B, left). In addition, we 
found that the SSR1/2-ECFP fragment co-purified with V5-SBP-Smaug1, whereas the ΔSSR1/2-ECFP 
construct was recovered less efficiently (Figure 6B, left). Conversely, V5-SBP-SSR1/2 significantly co-pulled 
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (whichthis version posted July 31, 2020. ; https://doi.org/10.1101/2020.07.31.223099doi: bioRxiv preprint 
Smaug- membraneess organelles regulate mitochondrial function                                                                                                                 page 6  
down Smaug1-ECFP and SSR1/2-ECFP (Figure 6B, right). In contrast, the ΔSSR1/2-ECFP construct was 
recovered less significantly and ECFP was almost absent from the material co-pulled down with V5-SBP-
SSR1/2. In all cases, a contribution of endogenous Smaug1 and Smaug2 that may bridge the transfected 
Smaug1 fragments together cannot be ruled out.   
Despite minor quantitative differences with the outcome of the imaging analysis described above –likely due to 
the harsher conditions of pull-down assays–, altogether these observations suggest that Smaug1 phase 
separation is driven by multiple protein regions. It likely involves SSR1 homodimerization and additional 
interactions between unknown protein motifs distributed along the molecule.  
We found that RNA regulation by Smaug1 affects mitochondrial function (Figure 4), and we wondered whether 
condensation of Smaug1-bodies is relevant as well. We found that truncated Smaug1 constructs that show 
defective body formation failed to rescue the mitochondrial phenotype (Figure 7). In three independent 
experiments, cells treated with siRNAs against Smaug1 and Smaug2 and transfected with V5-SBP-ΔSSR1/2 
or V5-SBP-ΔSSR1 showed mostly short mitochondria, with values similar to those of cells transfected with V5-
SBP-ΔSAM which, as seen in figure 4, did not rescue the phenotype. In contrast, transfection of full-length 
Smaug1 rescued the mitochondrial network complexity in most cells, as previously seen. We conclude that 
mitochondria depend on both RNA binding by Smaug and Smaug-body formation. 
 
Smaug1 MLO formation affects RNA binding  
We next investigated the consequences of defective Smaug1-body formation on RNA regulation. In order to 
uncouple RNA binding from translational repression, we used a MS2-tethering strategy, as previously 
described (Bhandari et al., 2014; Deng et al., 2015). Briefly, a firefly luciferase reporter carrying 6 MS2 binding 
sites (6xMS2bs) or a control reporter with no MS2 binding sites were co-transfected with the above described 
Smaug1 fragments fused to a double tag MS2-HA, to direct its tethering to the firefly luciferase reporter and to 
allow its detection by western blots, respectively. In six independent experiments, we found that Smaug1 
reduced firefly luciferase 6xMS2bs expression to about 50% of the control levels (Figure 8A). Deletion of SSR1 
and SSR2 repressed the reporter to the same extent (ΔSSR1/2, Figure 8A). As expected, tethering of the 
ΔSAM construct repressed the reporter similarly to the full length Smaug1, while tethering the SAM domain 
had no effect (Figure 8A). For comparison, the effect of SMG7 –a key factor of the non-sense mediated decay 
pathway– was analyzed and found to strongly repress the luciferase reporter (Figure 8A). RNA levels were not 
affected by tethering of either full length or truncated Smaug1 constructs, whereas SMG7 induced a significant 
decay (51±4% relative to the MS2 control). Similar results were observed in HEK293T (Figure 8A) and U2OS 
cells, where Smaug1-MS2-HA repressed the reporter to 55±5%; ΔSSR1-MS2-HA, to 57±10% and ΔSSR1/2-
MS2-HA, to 48±6%, whereas tethering of the SAM domain elicited no effect.  
Theoretically, the 6 MS2 binding sites present in the firefly luciferase reporter may tether up to 6 protein 
molecules, and we considered whether this may drive the phase separation of the otherwise “soluble” Smaug1 
deletion constructs. Confocal imaging analysis indicated that less than 10% of the cells co-transfected with 
ΔSSR1/2-MS2-HA and the 6xMS2bs reporter showed microscopically visible puncta after staining of HA, 
whereas, as expected, more than 50% of the cells co-transfected with Smaug1-MS2-HA and the 6xMS2bs 
reporter showed Smaug1-MS2-HA bodies. The presence of nanoscale condensates cannot be ruled. 
Collectively, these observations indicate that the formation of Smaug1-bodies does not significantly affect 
mRNA repression when Smaug1 is strongly tethered to multiple sites in the target transcript.  
Next, we investigated whether Smaug1 phase separation affects the interaction with endogenous mRNAs. We 
focused on SDHB and UQCRC1 mRNAs, which associate to Smaug1 MLOs and co-purified with Smaug1 
(Figure 1). As expected, whereas SDHB and UQCRC1 mRNAs showed a three-fold enrichment in the Smaug1 
pull-down, the construct lacking the SAM domain failed to bind to these transcripts (Figure 8B). Relevantly, we 
found that deletion of either the SSR1 or the N-terminal region including SSR1 and SSR2 moderately impaired 
the recovery of SDHB and UQCRC1 mRNAs. In several independent experiments, the pull-down of 
condensation-defective V5-SBP-ΔSSR1 or V5-SBP-ΔSSR1/2 (Figure 5C) recovered 60-75% of the amount of 
mRNA that co-purified with the full-length construct (Figure 8B). In all cases, we found that the amount of 
SDHB and UQCRC1 mRNAs in the whole extract remained unaltered. Expression levels and pull-down 
recovery of the V5-SBP-tagged constructs were confirmed to be quantitatively similar by western blot 
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(Supplementary file 4). These results indicate that the Smaug1-body formation helps –but it is not strictly 
required– for the interaction of Smaug1 with its target mRNAs.  
 
Mitochondrial activity affects Smaug1-body condensation  
The above observations suggest that the condensation of Smaug1-bodies contributes to the regulation of 
mitochondrial relevant mRNAs. We further speculated that Smaug1-bodies may respond to changes in 
mitochondrial activity, which we manipulated by pharmacological approaches. We assessed the effect of 
complex I inhibition by rotenone on Smaug1-bodies detected by staining of the endogenous molecule. We 
found that exposure to rotenone for one hour induced the dissolution of the Smaug1-bodies in a significant 
proportion of cells. On average, the number of cells with Smaug1-bodies dropped to 66% the basal values. 
Smaug1-body disappearance did not correlate with mitochondrial fragmentation (Figure 9A). Smaug1-EYFP 
bodies were similarly affected and we found that the proportion of cells with Smaug1-EYFP bodies was 
reduced from 66 % to 42 % after 1h exposure to rotenone. In contrast, strong depolarization by CCCP elicited 
no effect on Smaug1-EYFP bodies (Figure 9B), while seriously affecting the mitochondrial network (Figure 2C-
D and Figure 3B). These observations indicate that Smaug1-body disappearance does not correlate with 
mitochondrial damage or fragmentation but rather with complex I inhibition.  
Dissolution of PBs, SGs, Smaug1-bodies and related MLOs can be the consequence of translation activation. 
We analyzed the effect of rotenone and CCCP in the global translation rate, which we measured by puromycin 
incorporation. Briefly, cells were exposed to a short pulse (5 min) of puromycin, which was then detected by 
immunofluorescence. As expected, rotenone and CCCP seriously reduced translation (Fessler et al., 2020)  
(Figure 9C). These observations indicated that Smaug1-body dissolution does not correlate with changes in 
global translation. 
Next, we investigated the effect of metformin, a drug highly relevant in the clinics that regulates the energetic 
metabolism through multiple pathways including inhibition of mitochondrial complex I (Hawley et al., 2002; 
Wheaton et al., 2014). We found that the number of cells with Smaug1-bodies detected by staining of 
endogenous Smaug1 decreased to about 2/3 of the basal values after 1-hour treatment with 100 µM metformin 
(Figure 10 A). In accordance with previous observations (Izzo et al., 2017; Wang et al., 2017) metformin 
elicited no effect on the mitochondrial network. In addition, we found that metformin moderately reduced 
puromycin incorporation (Figure 9C), suggesting that translation rate is slightly downregulated, as reported 
previously (Larsson et al., 2012).  
Smaug1-EYFP bodies responded similarly to metformin in a dose-dependent manner (Figure 10B). The 
number of cells with Smaug1-EYFP bodies was reduced to half of the control values after 1-hour exposure to 
100 µM metformin (Figure 10B). Time-lapse confocal microscopy of Smaug1-EYFP transfected cells showed 
that the response is fast. As in fixed cells, we found that about half of the cells responded to metformin 
exposure and in responsive cells Smaug1-EYFP bodies started to dissolve immediately after treatment. 
Smaug1-EYFP bodies showed a gradual reduction in size and /or fluorescence intensity and a significant 
proportion of bodies completely vanished (Figure 10C-D, Video1-2).  
We have previously shown that synapse activation can induce Smaug1-body dissolution and the release of 
specific mRNAs together with a global translational shutdown (Baez et al., 2011; Luchelli et al., 2015). We 
speculated that similarly, Smaug1-body dissolution upon exposure to metformin is linked to the release of 
mRNAs bound to Smaug1. We performed co-pulldown assays as before (Figure 1) and found that the 
exposure to metformin reduced the amount of SDHB mRNA that co-pulled down with V5-SBP-Smaug1, 
whereas SDHB mRNA total levels remained unchanged (Figure 11A-B). Binding of UQCRC1 mRNA was 
affected to a lesser extent. Collectively, these observations indicate that metformin triggers Smaug1-body 
dissolution and the release of associated mRNAs. Whether released transcripts are then engaged in 
translation remains to be investigated.   
 
Discussion  
Here we report that defective Smaug1 MLO condensation correlates with altered mitochondrial function. In 
addition, Smaug1 MLOs contain SDHB and UQCRC1 mRNAs and exposure to mitochondrial inhibitors rapidly 
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triggers Smaug1-body dissolution and mRNA release. We hypothesize that dynamic Smaug1-body formation 
links mitochondrial function with the regulation of mRNAs that encode mitochondrial enzymes (Figure 11C). 
 
As reported before in neurons, we found that Smaug1-bodies in U2OS cells exclude the translational 
apparatus and dissolve when mRNAs are trapped into polysomes –as exemplified by cycloheximide exposure 
(Figure 1)–, supporting the notion that Smaug1-bodies contain repressed mRNAs that can be released to enter 
translation. Smaug1-bodies are different from PBs, which coordinate the expression of sets of mRNAs 
functionally related and termed “RNA regulons” (Hubstenberger et al., 2017). In addition to UQCRC1 and 
SDHB mRNAs a number of transcripts that code for mitochondrial enzymes were reported to bind Smaug 
orthologs, thus defining a mitochondrial regulon linked to Smaug-bodies (Chartier et al., 2015; Chen, Dumelie, 
et al., 2014; Tadros et al., 2007). The collective dysregulation of SDHB, UQCRC1 and additional mRNAs is 
likely the direct cause of the serious mitochondrial phenotype provoked by Smaug1 loss of function, 
characterized by altered OXPHOS activity and disrupted mitochondrial network. 
 
Current models for MLO formation propose that multiple protein-protein interactions together with protein-RNA 
and RNA-RNA contacts direct a LLPS process which eventually drive the condensation of ribonucleoparticles 
in specific bodies (Courchaine et al., 2016; Guo & Shorter, 2015; Perez-Pepe et al., 2018; Sachdev et al., 
2019; Van Treeck et al., 2018). MLOs involved in mRNA regulation can be complex in composition and several 
factors that interact with Smaug orthologs, including Argonaute, 4E-binding proteins and deadenylase 
complexes might additionally help Smaug1-body formation (Amadei et al., 2015; Chartier et al., 2015; Nelson 
et al., 2004; Pinder & Smibert, 2013). We were able to identify conserved Smaug1 domains involved in 
Smaug1-body formation. We propose that SSR1 dimerization and additional interactions involving further 
protein regions act together with RNA binding to direct Smaug1 phase separation. We found that Smaug1 
condensation does not directly influence translation repression but affects the interaction with target mRNAs 
(Figure 8). Among several mechanisms, the presence of multiple RNA-binding domains in the Smaug1-body 
will increase the avidity for mRNA molecules. A similar model was proposed for the yeast ortholog Vts1 
(Bieman, 2014).  
 
We found that defective Smaug1-body condensation elicits a moderate effect in RNA binding while 
mitochondria are severely affected (Figure 7). We propose that the mitochondrial defects are the consequence 
of concurrent mechanisms that remain to be further investigated. First, a single Smaug1-body may contain 
several mRNA species, as exemplified here by UQCRC1 and SDHB mRNAs, whose co-occurrence in 
Smaug1-bodies is higher than random (Figure 1F). This may enable the coordinated regulation of several 
target mRNAs. Second, Smaug1-bodies contact mitochondria and we speculate that this may help local 
regulation. Several nuclear messengers that encode mitochondrial proteins including complex I and II subunits 
are translated at the mitochondria periphery in yeast, plant and animal cells. Localized translation can enable 
co-translational import and assembly, thus helping the biogenesis of multi-subunit complexes (Gehrke et al., 
2015; Schatton & Rugarli, 2018; St-Pierre & Topisirovic, 2016; Vincent et al., 2017; Wilk et al., 2016; Williams 
et al., 2014; Wu et al., 2018). Relevantly, biogenesis of succinate dehydrogenase complex involves a strict co-
translational control with the participation of multiple co-factors, and mutations in assembly factors lead to 
serious mitochondrial defects (reviewed in (Moosavi et al., 2019)). This highlights the significance of the co-
translational regulation of SDH and additional ETC complexes, many of them under Smaug control (Chartier et 
al., 2015; Chen, Dumelie, et al., 2014; Tadros et al., 2007). Smaug bodies may parallel the function of MLOs 
formed by the RNA binder Tis11, which associates to the ER thus influencing ER-associated translation 
(Bethune et al., 2019; Ma & Mayr, 2018). Our observations suggest that Smaug1+2 bodies may affect 
mitochondria-associated translation, by helping mRNA transport and/or allowing coordinated mRNA de-
repression upon dissolution. These important hypotheses are worthy of further studies.  
 
Translation of mitochondrial enzymes responds to mitochondrial physiology and energetic balance (Bethune et 
al., 2019; Gao et al., 2014; Schatton et al., 2017; Wakim et al., 2017; Wu et al., 2018). Relevantly, along with 
the significance of Smaug1-body formation to mitochondrial function, we found that acute complex I inhibition 
triggers Smaug1-body dissolution (Figure 9 and 10, and videos 2 and 3). We have recently shown that 
Drosophila Smaug MLOs are affected by Smoothened (Smo), a key molecule in the Hedgehog (HH) pathway 
(Bruzzone et al., 2020). Whether Smaug regulation by Smo is conserved in mammals and whether this may 
occur in connection with mitochondrial activity is currently unknown. Messenger RNA release from dissolving 
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MLOs is linked to translation (Khong & Parker, 2018; Moon et al., 2019) and thus, we speculate that Smaug1-
body dissolution allows the translation of SDHB, UQCRC1 and other enzymes to recover mitochondrial 
function. Remarkably, rotenone and metformin trigger Smaug1-body dissolution along with widespread 
translational repression, as similarly occurs in neurons exposed to specific neurotransmitters (Baez et al., 
2011; Luchelli et al., 2015). Collectively, these observations suggest that Smaug1-bodies respond to specific 
cellular cues to release selected mRNAs, yet at the same time most messengers are massively repressed, 
thus providing a mechanism for selective translation (Thomas et al., 2014). To our knowledge, Smaug1 bodies 
are the first mRNA-containing MLO that can respond to mitochondrial activity.  
 
The role of Smaug orthologues as post-transcriptional regulators of energetic metabolism appears evolutionary 
conserved as yeast Vts1p –which forms MLOs and prion-like condensates– controls mRNAs linked to nutrient 
sensing (Chakravarty et al., 2020; She et al., 2017). Translation of nuclear-encoded transcripts at the 
mitochondrial periphery is known to be regulated by a reduced number of RNA-binding proteins, including the 
highly conserved factors clustered mitochondria homolog (CLUH) and Pumilio orthologs (reviewed in(D'Amico 
et al., 2019; Gao et al., 2014; Gehrke et al., 2015; Kopp et al., 2019; Lee & Tu, 2015; Olivas & Parker, 2000; 
Pla-Martin et al., 2020; Schatton et al., 2017; Schatton & Rugarli, 2018; Vardi-Oknin & Arava, 2019; Wakim et 
al., 2017) The putative interplay between these pathways and Smaug remains to be investigated.   
 
Besides its relevance to cancer and diabetes, mitochondrial activity is particularly important in normal tissues 
with high energy demands, including neurons and muscle cells. Mitochondrial defects are causative of several 
neurological conditions and muscular dystrophies (Friedman & Nunnari, 2014; Gan et al., 2018; Kriaucionis et 
al., 2006; Rangaraju et al., 2019; Rugarli & Langer, 2012; Shan et al., 2019). The strong effect of Smaug1 and 
2 in neuronal development and maturation, and in muscular cells in connection with myopathies is likely related 
to the relevance of Smaug to mitochondrial function (Amadei et al., 2015; Baez et al., 2011; Chartier et al., 
2015; Chen, Holland, et al., 2014; de Haro et al., 2013; Luchelli et al., 2015). The present work opens new 
questions on the motility and dynamics of Smaug-bodies in a wide diversity of cellular contexts. A major issue 
to be addressed is how these MLOs respond to metabolic cues and what are the consequences in the 




Materials and Methods 
 
Cell culture and treatments 
U2OS and HEK293T cells were obtained from the American Tissue Culture Collection (ATCC) and grown and 
maintained as indicated. Cell lines were transfected with Jet Prime (Polyplus Transfection) according to 
manufacturer’s instructions.  
 
pCDNA6-V5-hSmaug1 (Smaug1-V5) and pECFP-N1-hSmaug1 (Smaug1-ECFP) constructs were previously 
described (Baez y Boccaccio 2005). Smaug1-EYFP was prepared by direct sub-cloning of pECFP-N1-
hSmaug1 into pEYFP-N1. ΔSAM-hSmaug1-ECFP and ΔSAM-hSmaug1-EYFP with a deletion of amino acids 
318 to 424 were constructed by SOE-PCR using ECFP-ΔC-hSmaug1 and hSmaug1-ECFP as templates and 
the following primers (SOE-1: 5’-GCGAGCCTCGGGTGTGTTACGAGC-3, SOE-2: 5’-
GCTCGTAACACACCCGAGGCTCGC-3’). ΔSAM -hSmaug1-V5 was obtained by insertion into pcDNA6.0-B-
His-V5 using HindIII/XhoI restriction digestion. ECFP-ΔC-hSmaug1 which comprises amino acids 2 to 418 was 
constructed by PCR using T7 forward and 5’AAGGCGAGCCTCGAGGGTG-3’ reverse primers and pCDNA6-
V5-hSmaug1 as template with XhoI/HindIII deletion fragment inserted in a SalI/HindIII pECFP-C3 digested 
vector. ΔSSR1-hSmaug-V5 spans amino acids 54 to 718 and was constructed by PCR using forward primer 
5´GCTCCCAAGCTTACCATGGAGCTGCACGTCCTCGAACG 3 ´ and reverse primer 5´ 
GCTCCGCTCGAGAAGATGGTGGAGGTCCGGTCAAC 3´ and hSmaug1-V5 as template and pcDNA6.0-B-
His-V5 as vector. SSR1/2-hSmaug1-ECFP was constructed by insertion of a HindIII/SalI fragment into pECFP-
N1 and spans amino acids 2 to 154. All MS2-HA constructs were obtained by PCR using primers carrying 
BamHI and XhoI restriction sites into the pcDNA3.1-MS2-HA (Lykke-Andersen et al., 2000). V5-SBP- 
hSmaug1 was cloned by PCR using primers carrying XhoI and BamHI sites into pT7-V5-SBP (Sgromo et al., 
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2017). V5-SBP-ΔSAM-hSmaug1 was sub-cloned by KpnI/BamHI restriction of ΔSAM-hSmaug1-ECFP. V5-
SBP-ΔN-hSmaug1 was cloned by BamHI/SacII digestion into a BglII/SacII pT7-V5-SBP-C1 digested plasmid. 
V5-SBP-ΔN-hSmaug1 was cloned by BamHI/EcoRI digestion into a BglII/EcoRI pT7-V5-SBP-C1 digested 
plasmid.  
 
For knock-down experiments, U2OS cells were treated with 50 nM siRNAs using Jet Prime transfection 
reagent for 48 hs following the manufacturer’s instructions. siRNAs were obtained from Dharmacon or Eurofins 
and were: NT, UAGCGACUAAACACAUCAA; Samd4A mix: 1- GACCAGAGGGUUUGCGAA, 2- 
CUACAGGUAUAUAGCUCAA, 3-CUUAAUGAAAUCCGAACAA, and 4-GAUGGAAAUGACAGCGCUA; 
Samd4B mix, or sequences 1 or 4 alone: 1-ACACAGAGGCCAAGUCGGA, 2-CAUGAGGCUUUCACGGAGA, 
3-AUCCAGAAGCUGCGUGAGA, 4-GCUGAAGCUCCUCCGGACA.  
 
Drugs treatments were as follows: metformin hydrochloride (Sigma-Aldrich) was dissolved in H2O and used 
during 1h at 500 µM, unless otherwise indicated. Rotenone was used at 2µg/ml (from a stock solution 50mg/ml 
in DMSO) during 1h unless otherwise indicated. Carbonyl cyanide m-chlorophenyl hydrazine (CCCP) was used 
20 µM (from a stock solution 100 mM in DMSO) during 1 h unless otherwise indicated. To induce SIMH, cells 
were exposed to 1μM cycloheximide for 3 hours (Ehses et al., 2009; Tondera et al., 2009). 
 
Immunofluorescence, fluorescent in situ hybridization and puromycilation 
Immunofluorescence of cultured cells was performed after fixation, permeabilization and blocking as usual 
(Baez et al., 2011; Fernandez-Alvarez et al., 2016; Luchelli et al., 2015). Primary antibodies were diluted as 
follows: V5 1:500, anti-SAMD4A HPA043061 (Sigma) 1:20, anti-Ubiquitin Ubi-1 ab7254 (abcam) 1:500, anti-
DRP1 EPR19274 (abcam) 1:250, anti-TOM20 sc-17764 (Santa Cruz) 1:200. Secondary antibodies coupled 
to Alexa Fluor 488 (Invitrogen) or Cy3 (Jackson Immuno Research Laboratories, Inc.) were used at 1:300–
1:500. For Mito TrackerTM Red CMXRos (Invitrogen) staining, cells were incubated during 45 min at 37ºC with 
400 nM Mito Tracker and washed three times with conditioned media prior to PFA fixation.  
 
FISH for ribosomal RNA was performed using digoxigenin-labelled riboprobes as previously described 
(Thomas et al., 2005). Single-molecule FISH with Stellaris probes (Biosearch Technologies) was performed 
according to manufacturers’ instructions.  
 
Labelling of translating polypeptides was performed by incubating the cells in complete medium with 10 nM 
puromycin (SIGMA) during 10 min, followed by fixation and detection with anti-puromycin (PMY-2A4, DSHB) 
and Alexa Fluor 488 secondary antibody. Fluorescence intensity in single cells was measured using ImageJ, 
(https://imagej.nih.gov/ij/) and average from 100 cells was calculated for each experimental point in duplicate 
coverslips.  
 
Images were acquired with PASCAL-LSM, LSM510 Meta, or LSM 880 confocal microscopes (Carl Zeiss), 
using C-Apochromat 40×/1.2 W Corr or 63×/1.2 W Corr water immersion objectives for the PASCAL-LSM, an 
EC “Plan-Neofluor” 40×/1.30 NA oil or Plan-Apochromat 63×/1.4 NA oil objective lenses for the LSM510 Meta, 
and a Plan-Apochomat 63x/1.4 Oli DIC M27 objective for the LSM880. Pixel intensity was always lower that 
250 (saturation at 255). Cell contours in Figures 1B and 1E were manually drawn using saturated 
immunofluorescence images as templates.  
 
Image analysis  
To evaluate the presence of Smaug1-bodies or Smaug1-EYFP bodies in fixed cells, cells were manually 
classified as positive when more than three bodies of at least 0,25 µm in diameter were present. For smFISH 
confocal images, we used a previously described strategy (Luchelli et al., 2015) to evaluate the frequency of 
stochastic contacts of SDHB and UQCRC1 mRNAs with Smaug1 ECFP-bodies. Three cognate images of the 
Smaug1-body channel were generated by flipping and/or mirroring the original and colocalization was manually 
inspected. A total of 400 Smaug1-ECFP bodies from randomly-selected cells were analyzed and 3 to 7 ROIs 
covering almost all the cell cytosolic area were analyzed. Contacts with mitochondria were manually evaluated 
and the frequency of random events was evaluated in randomized images of Smaug1. At least five rectangular 
ROIs of 50 µm2 per cell were randomly selected, where mitochondria signal covered 30% to 50%.   
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Confocal live-cell imaging   
A Carl Zeiss LSM 880 inverted confocal microscope equipped with a stage-top heated platform maintained at 
37°C and with a controlled CO2 flux chamber was used. U2OS cells were grown and transfected in 8 wells 
Nunc® Lab-Tek chamber slides. U2OS cells expressing hSmaug1-EYFP and Mito-DsRed were imaged 24 hs 
after transfection. Metformin was injected to slides without opening the CO2 chamber. Z-stack images were 
obtained for each cell every two minutes. For image analysis, acquired z-stacks were processed with a 
custom-made Python script to segment and quantify the intensity and morphological properties (Malik-Sheriff et 
al., 2018) of the Smaug1-EYFP bodies. The segmentation pipeline consisted in filtering the hSmaug1-EYFP 
channel with Laplacian of Gaussian filters and using manual thresholding to distinguish between pixels 
corresponding to Smaug1-EYFP bodies from background pixels. Smaug1-body pixels were later disregarded 
to distinguish between background and cytoplasm pixels. To analyze the effect of metformin, the number of 
Smaug1-EYFP bodies at each time point was normalized to the pre-treatment value for each cell. Afterwards, 
quantifications were binned every 4 minutes and averaged. For error estimation, error of the mean was used. 




WB were performed by standard procedures using polyvinylidene fluoride membranes (Immobilon-P 
polyvinylidene difluoride, Millipore), ECL Prime (GE Healthcare) and analyzed using a LAS4000 Imager (GE 
Healthcare). Primary antibodies were used as follows: anti- SAMD4A HPA043061 (Sigma) 1:100; anti-
SAMD4B HPA059385 (Sigma) 1:100, mouse anti-V5 (Invitrogen) 1:5,000, anti-GFP (Invitrogen) 1:2,000; anti-
tubulin (DSHB) 1:10,000, anti-β-actin (Sigma-Aldrich) 1:10,000, anti-DRP1 EPR19274 (abcam) 1:1000, 
anti-OPA1 EPR11057(B) (abcam) 1:1000, anti-Mitofusin 2 6A8 (abcam) 1:1000, anti-TOM2O sc-
17764 1:100. HRP-conjugated secondary antibodies were used 1:10,000 or 1:100,000. Signal intensity was 
assessed with the ImageJ software. 
 
 
Respiratory parameters and mitochondrial membrane potential  
Oxygen flow in U2OS cells under ADP excess (state 3) was measured using a two-channel, high-resolution 
Oxygraph respirometer (Oroboros, Innsbruck, Austria), as described in (Doerrier et al., 2018). Briefly, cells 
were treated with the indicated siRNAs during 48hs and harvested at 90% confluence in trypsin-EDTA, washed 
once with phosphate buffered saline (PBS), resuspended in fresh growth media without antibiotics at a density 
of 1 × 106 cells/ml, and analyzed in 2 ml Oxygraph chambers under continuous stirring at 750 r.p.m. at 37°C in 
2 s intervals. For intact cell analysis, routine respiration was recorded and then 2.5μM oligomycin were added 
to inhibit the ATP synthase, which allows to measure leak respiration. The electron transfer system (ETS) 
capacity was evaluated by titration with carbonyl cyanide m-chlorophenyl hydrazone (CCCP) uncoupler in 
0.5 μM steps until a maximum flow was reached. Respiration was inhibited by 0.5 μM rotenone and 2.5 μM 
antimycin A to determine residual oxygen consumption (ROX). For digitonin-permeabilized cells, a substrate-
uncoupler-inhibitor-titration protocol termed SUIT-RP2 (Doerrier et al., 2018) was performed. Oxygen flow was 
measured before digitonin treatment in respiration medium MiR05 (Routine), and after successive addition of 
substrates and inhibitors as follows: 5 mM ADP, 0.1 mM malate, 0.2 mM octanoyl-carnitine, to record the 
electron-transferring flavoprotein complex from fatty acid b oxidation to coQ (F pathway); 2 mM malate, 5 mM 
pyruvate, 10 mM glutamate to record OXPHOS in the N-junction (Frostner et al., 2019) 10 mM succinate to 
record the OXPHOS capacity state FNS with convergent input of electrons via complexes I and II into the 
respiratory system, 10 mM glycerol-3-phosphate to activate the glycerophosphate dehydrogenase shuttle; 
stepwise titration with CCCP in 0.5 μM increments as needed to determine the ETS capacity state at maximum 
oxygen flow; 0.5 μM rotenone for complex I inhibition. All respiratory coupling states were corrected for ROX, 
which was obtained after the addition of 2.5 µM antimycin A. Finally, 5mM ascorbate plus 0.5mM N,N,N′,N′-
tetramethyl-p-phenylendiamine dihydrochloride (TMPD) were used as substrates to assess complex IV activity. 
Mitochondrial membrane integrity was verified after addition of 10 μM cytochrome c, and changes were always 
lower than 10%. Data was analyzed using DatLab7.4.0.4 software (Oroboros, Austria). Oxygen flow is 
expressed as picomoles per second per million cells and normalized to the mitochondrial DNA content in each 
sample (pmol/ S*millcells*mtDNA). All experiments were performed using instrumental background correction 
and after calibration of the polarographic oxygen sensors. Statistical significance was calculated using Mann-
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Whitney rank-sum test using SPSS IBM for Windows statistical package, version 26 (SPSS Inc, Chicago, IL, 
USA) 
 
Mitochondria depolarization was assessed with the MitoProbe 5ʹ,6,6ʹ-tetrachloro-1,1ʹ,3,3ʹ-
tetraethylbenzimidazolylcarbocyanine iodide (JC-1). For cytometry assay, cells were treated with trypsin, 
resuspended in complete DMEM, washed twice with PBS and incubated with 2 μM JC-1 dissolved in pre-
warmed PBS at 37 °C, 10% CO2 during 20 min and analyzed by flow cytometry.Exposure to 100 µM CCCP to 
induce complete depolarization was  done during 5 min before incubation with JC-1. Flow cytometry analysis 
was performed using a FACS Aria (Becton Dickinson, Franklin Lakes, NJ, USA) and data mining was done 
using FlowJo (Tree Star, Inc., Ashland, OR, USA). Fluorescence intensity of J-aggregates (red) and JC-1 
monomers (green) was measured in the mCherry and FITC channels. CCCP-treated cells were used to set 
gates. Geometric means normalized to siNT-treated cells were calculated. Confocal live-cell imaging was 
performed using a Carl Zeiss LSM 880 inverted confocal microscope as described above. Cells were seeded in 
Lab-tek chamber slides and incubated with JC-1 and CCCP as above. Images were obtained using a 20X 
objective and 488/ 543 nm lasers and fluorescence intensity was analyzed using ImageJ. 
 
Pull-down assays 
Cells were grown in 100 mm-plates and transfected with a mix of 250 ng of VSBP-V5 tagged constructs and 
250 ng of EYFP constructs. After 24 hours of expression, cells were harvested with 500 µl of NET buffer (150 
mM NaCl, 50 mM Tris pH7.5, 1 mM EDTA and protease inhibitor cocktail from Sigma). Cells were kept on ice 
for 15 minutes and lysed by 20 times up and down pipetting. After a 15-min centrifugation to remove cell debris 
the supernatant (input, IN) was incubated for 1 hour at 4ºC with Streptavidin-conjugated beads. After three 
washes in NET buffer supplement with 0.1% TX100 and one wash in NET buffer, pulled-down proteins were 
cracked in protein sample buffer and subjected to western blot for EYFP and/or V5. 
 
Tethering assays 
Tethering assays were performed as previously described (Bhandari et al., 2014; Deng et al., 2015). In brief, 
HEK293T cells were transfected at 50% confluency with a mix of 250 ng of Smaug1-MS2-HA constructs, 200 
ng of Firefly-6xMS2bs plasmid or control firefly and 50 ng of pCIneo-Renilla for 24 hs in 24-wells plates using 
Jet Prime reagent following the manufacturer’s instructions. Luciferase expression levels were analyzed using 
the Dual Luciferase kit (Promega) in a DTX880 Multimode detector (Beckman Coulter). 
 
RNA pull-down assays 
Cells grown in 100 mm plates were transfected with 10 µg of V5-SBP tagged constructs and harvested 24 hs 
afterwards in 400 µl of RPD buffer (150 mM NaCl, 25 mM Tris pH7.4, 5 mM EDTA, 0.5 mM DTT, 1% NP40, 5% 
glycerol and protease inhibitor cocktail from Sigma). Cells were lysed using a Bioruptor (Diagenode) and after 
centrifugation, pull-down was performed with Streptavidin-conjugated beads. Total RNA from pull-down or input 
samples was isolated using TRIzol LS reagent (Invitrogen) following the manufacturer’s instructions. First-strand 
cDNA was synthesized from 2 µg of total RNA using random hexamers and MMLV reverse transcriptase 
(Promega). The cDNA was used as a template for quantitative PCR performed using Syber Green reagent 
(Applied Biosystems) and the Light Cycler 480 system (Roche). The amount of the indicated mRNAs relative to 
RpLp0 was determined using specific primers. Binding is expressed as the relative amount of mRNA in the pull-
down material normalized to the relative amount in the input sample. The levels of the tagged constructs in the 
inputs and pulled-down material were measured by western blot using anti-V5 antibody. Sequences of primers 
were as follows: NDUFA10 Fw. AGTACTCAGATGCCTTGGAG and Rv, GCTCCAACACAACACCTTGTC; 
UQCRC1 Fw, CCTCTCAGCCCACTTGCA and Rv, CGGCTGCCAACATCAAT; SDHB Fw, 
GTGGCCCCATGGTATTGGAT and RV, CACAAGAGCCACAGATGCCT; PPIA Fw, 
TTCATCTGCACTGCCAAGAC and Rv TCGAGTTGTCCACAGTCAGC; RpLP0 Fw, 
GGGCAAGAACACCATGATGC and Rv CATTCCCCCGGATATGAGGC.  
 
Statistics 
Each experimental point included duplicate or triplicate coverslips or wells. Cell numbers are indicated in each 
figure panel. Statistical significance was determined using Excel or Instat software (GraphPad Software, Inc.) 
in all figures unless indicated. P-values (*, P < 0.05; **, P <0.01; ***, P < 0.001; ns, not significant) relative to 
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control treatments were obtained by one-way ANOVA and Tukey post-test. Error bars represent standard 
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Figure 1. Smaug1-bodies contain mRNAs that encode mitochondrial enzymes.  
(A) U2OS cells were immunostained for DCP1A and Smaug1. (B) Cells were exposed to 1µM cycloheximide 
for one hour. Representative cells from each condition are depicted. The proportion of cells with Smaug1-
bodies evaluated as described in Materials and Methods is indicated. Cell contours (orange) were drawn as 
described in Materials and Methods. 
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Figure 1. cont. 
(C) Smaug1-EYFP was recorded in live cells. Inset, two bodies (empty arrowheads) start merging at 2 min and 
remain fussed in a single body (full arrowhead). Fusion with a third body starts at 18 min. (D) RNA pull-down. 
Smaug1, Smaug1 ΔEIII or MBP as a negative control, all of them tagged with V5-SBP were pulled-down and 
the presence of the indicated transcripts in the pulled-down material was analyzed by qRT-PCR. Mean values 
from three independent experiments of pull-down/input ratio for each transcript normalized to ribosomal protein 
RpLp0 are plotted. Error bars, standard deviation. Expression levels and recovery of V5-SBP-tagged 
constructs were confirmed to be similar by western blot (not shown). (E) Single molecule FISH for SDHB and 
UQCRC1 mRNAs was performed in cells expressing Smaug1 EYFP. Cell contour (solid line) was drawn as 
described in Materials and Methods. (F) Three adjacent confocal slices and maximal projection of 
representative Smaug1-EYFP bodies containing SDHB mRNA, UQCRC1 mRNA, or both transcripts are 
depicted. Colocalization was analyzed in 400 Smaug1-ECFP bodies from randomly-selected cells and 
indicated as percentage. Stochastic colocalization (in brackets) was assessed in randomized images as 
described in Materials and Methods. (G) Smaug1 and TOM20 were immunostained. Arrowheads, examples of 
Smaug1-bodies that contact mitochondria. (H) Smaug1-EYFP transfected U2OS cells were live-stained with 
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Figure 2. Respiratory defects upon Smaug1 and Smaug2 knockdown.  
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Figure 2. cont 
(A) U2OS cells were treated with siRNAs against Smaug1 (S1) and/or Smaug2 (S2) during 48 hs and mRNA 
and protein levels were respectively analyzed by qRT-PCR and western blot. A representative qRT-PCR out of 
three is shown and two independent experiments were averaged for quantification by western blot. NT, non-
targeting siRNA. (B) High resolution respirometry in permeabilized cells. Top, representative traces of oxygen 
concentration (blue) and oxygen flow (red). The addition of digitonin (Dig), ADP (D), 0.1 mM malate (M1), 
octoanylcarnitine (Oct), cytochrome c (C), 2 mM malate (M2), pyruvate (P), glutamate (G), succinate (S), 
phosphoglycerate (Gp), CCCP (U1-U5), rotenone (R) and antimycin A (A) is indicated with dotted lines as well 
as re-oxygenation and closing of the chambers (oc and cc, respectively). Sections reflecting OXPHOS 
fingerprints (see Methods) are labelled. Bottom, oxygen flow was measured as described in Material and 
Methods. Mean oxygen flow per million cells ± SE from three independent experiments performed in duplicate 
are shown. Statistical significance was calculated as described in Materials and Methods, p values lower than 
0.1 are indicated. (C-D) Mitochondrial membrane potential was determined using JC-1 dye. (C) J-aggregates 
(shown in magenta) and monomers (green) were analyzed by confocal microscopy. The proportion of 
aggregates/monomers calculated as the average intensity ratio from 10 fields from a representative experiment 
is plotted. (D) J-aggregates (red) or monomers (green) were analyzed in the mCherry and FITC channels 
respectively by flow cytometry. Histogram, overall green fluorescence (FITC). Bottom right, JC-1 monomer 
signal was quantified using geometric median from three independent experiments and plotted as fold change 
± S.E.M. Statistical analysis was done using Student’s t-test (paired, one tailed) (*P<0.05). 
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Figure 3. Mitochondrial network disruption upon Smaug1 and Smaug2 knockdown.   
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Figure 3. cont 
(A) U2OS cells were treated with the indicated siRNAs and immunostained for TOM20. At least 200 cells per 
treatment were analyzed and the percentage of cells with elongated mitochondria is plotted (B). A 
representative experiment out of three is shown. Scale bars, 10 μm. Error bars, standard deviation. (C) Cells 
were exposed to 2 µg/ml rotenone or 20µM CCCP for 1h or treated with the indicated siRNAs and whole 
protein extracts were analyzed by western blot for Opa1 and Mfn2. Opa1 L and S fragments are indicated. 
TOM20 and actin were analyzed as controls for mitochondrial content and protein loading respectively. In 
parallel, cells were immunostained for TOM20 and the fraction of cells with elongated mitochondria was 
counted in 200 cells from duplicate coverslips. (D) SIMH was induced as described in Materials and Methods 
and mitochondrial hyper-fusion was evaluated in at least 100 cells from duplicate coverslips for each 
experimental point. Means ± SD from two independent experiments are plotted (*, P < 0.05). Scale bars, 10 
μm. (E) TOM20 (magenta) and DRP1 (green) were immunostained and the number of DRP1 puncta per 1 μm 
mitochondria were determined in 5-10 ROIs from 40 cells for each treatment. Means ± SD from two 
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Figure 4. Smaug binding to RNA affects mitochondria.   
Smaug1, Smaug1 ΔEIII or Smaug1 ΔSAM tagged with V5-SBP were transfected simultaneously with siRNAs 
against Smaug1 and Smaug2. Cells were immunostained for TOM20 (magenta) and V5 (green). The fraction 
of cells with elongated mitochondria was determined in at least 200 cells from duplicate coverslips for each 
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Figure 5. A conserved region required for Smaug1-body formation.  
(A) Human Smaug1 splicing variants and deletion constructs analyzed in this work. (B-D) The indicated 
constructs tagged with V5-SBP were transfected in U2OS cells and analyzed by western blot (B) and 
immunofluorescence (C-D). Additional constructs tagged with V5 or ECFP were analyzed in independent 
experiments and the percentage of cells with cytosolic puncta was assessed by confocal microscopy. Duplicate 
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Figure 6. Protein-protein interactions mediate Smaug1-body formation.  
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Figure 6. cont. 
(A) Recruitment of the indicated Smaug1 fragments to Smaug1-EYFP bodies. U2OS cells were co-transfected 
with Smaug1-EYFP and the indicated ECFP-tagged constructs. Scale bars, 10 µm. ECFP signal intensity 
inside Smaug1-EYFP bodies relative to ECFP signal outside the bodies was measured in more than 150 
Smaug1-bodies from randomly selected cells, and averaged values are plotted. Error bars, standard deviation. 
(B) V5-SBP-Smaug1 or V5-SBP-SSR1/2 was co-transfected with ECFP; Smaug1-ECFP; SSR1/2-ECFP; or 
SSR1/2-ECFP. After pull-down with streptavidin-sepharose beads, the presence of V5- and ECFP-tagged 
constructs in cell lysates (IN) or pulled-down material (PD) was analyzed by western blot. A representative 
experiment out of three is depicted, and ECFP signal in the PD normalized to ECFP signal in the lysate is 
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Figure 7. Defective Smaug1-body formation correlates with mitochondrial defects.  
U2OS cells were treated with non-targeting siRNA (siNT) or with siRNAs against Smaug1 and Smaug2 and 
transfected with the indicated constructs tagged with V5-SBP (green). The mitochondrial network was analyzed 
by TOM20 immunostaining (magenta) in at least 200 cells from duplicate coverslips. A representative 
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Figure 8. Smaug1 condensation affects mRNA binding.  
(A) Tethering assay of the indicated Smaug1 constructs tagged with MS2-HA. Two firefly reporters –with or 
without a tandem array of 6 MS2 binding sites (6xBS)– were analyzed in parallel and normalized to a co-
transfected renilla reporter. The firefly/renilla ratio averaged from six independent experiments is plotted. Error 
bars, standard deviation. (B) RNA pull-down. The indicated constructs tagged with V5-SBP were pulled-down 
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Figure 9. Rotenone induces Smaug1-body dissolution.  
(A) U2OS cells were exposed to 2µg/ml rotenone for 1 hour and stained for Smaug1 (green) and TOM20 
(magenta). Two representative cells showing Smaug1-body disappearance upon rotenone with either 
elongated (upper panel) or fragmented mitochondria (lower panel) are depicted. The presence of Smaug1-
bodies was evaluated in at least 200 cells from duplicate coverslips for each condition as described in Material 
and Methods. Scale bars: whole cells, 10 μm, zooms, 1 μm. Error bars, standard deviation. (B) Cells 
transfected with Smaug1-EYFP were treated during 1 h with 2 µg/ml rotenone or 20 µM CCCP and analyzed 
by confocal microscopy. More than 200 cells in duplicate coverslips were analyzed for each experimental point. 
Scale bars, 10 µm. Error bars, standard deviation. (C) Cells were exposed to 2 µg/ml rotenone, 20 µM CCCP 
or 100 µM metformin for one hour and immediately incubated with puromycin during 5 min. Puromycin 
incorporation was analyzed with specific antibodies as described in Materials and Methods in at least 80 cells 
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Figure 10. Metformin induces Smaug1-body dissolution.  
(A) U2OS cells were exposed to 100 µM metformin (Met) and stained for Smaug1 (green) and TOM20 
(magenta). The presence of Smaug1-bodies was evaluated as in Figure 9. (B) Cells transfected with Smaug1-
EYFP were exposed during 1 h at the indicated metformin concentrations. More than 100 cells from duplicate 
coverslips were analyzed for each experimental point. Error bars, standard deviation. (C-D) Live cell imaging of 
U2OS cells transfected with Smaug1-EYFP and Mito-DsRed and exposed to 100 µM metformin. (C) Smaug1-
EYFP body number from four representative control and four metformin-treated cells normalized to pre-
treatment values as described in Material and Methods are plotted.  
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Figure 10. cont. 
(D) A representative control cell and a metformin-treated cell are shown at 0, 18, and 32 min after treatment 
initiation. Magnifications of the indicated areas with 2-min intervals from 0 to 32 min are shown. Scale bars, 
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Figure 11. Metformin reduces the interaction with target mRNAs.  
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Figure 11. cont. 
(A-B) U2OS cells transfected with V5-SBP-Smaug1 were exposed to 100 µM metformin for one hour and the 
co-pulldown of SDHB, UQCRC1 and PPIA mRNAs was determined by qRT-PCR as in Figure 1. Cells 
transfected with V5-SBP-ΔSAM were analyzed in parallel. (A) The pull-down/input ratio (upper panel) and total 
levels in the input samples (bottom panel), both normalized to RpLp0 mRNA values, are plotted for each 
transcript. Error bars, standard deviation. (B) Western blot of the input and pull-down (PD) samples revealed 
with anti-V5 antibody. (C) Proposed model. Protein-protein interactions including SSR1 homodimerization drive 
Smaug1-body formation (green). Additional proteins (yellow) are expected to be present in Smaug1-bodies and 
whether Smaug2-bodies are separate MLOs is currently unclear. Smaug1-bodies contain mRNAs that encode 
mitochondrial proteins, including SDHB and UQCRC1 and likely many others. Changes in mitochondrial 
activity triggers Smaug1-body dissolution and mRNA release, likely enabling their coordinated translation, 








Video 1. (Linked to Figure 1C). A representative Smaug1-EYFP transfected cell was recorded during 30 min 
as described in Materials and Methods. 
 
Video 2. Live cell imaging of the control cell depicted in Figure 10D. Smaug1-EYFP (green) and Mito-dsRED 
(magenta) were co-transfected.  
 
Video 3. Live cell imaging of the metformin-exposed cell depicted in Figure 10D. Smaug1-EYFP (green) and 
Mito-dsRED (magenta) were co-transfected.  
 
 
Supplemental Figure 1. Smaug1-bodies exclude ubiquitin and small ribosomal subunits. 
Top, Smaug1-V5-transfected U2OS cells were immunostained for V5 and ubiquitin. Bottom, Smaug1-EYFP-
transfected U2OS cells were submitted to FISH with a ribosomal 18S riboprobe as described in Material and 
Methods. Both markers are excluded from Smaug1-bodies. 
 
Supplemental Figure 2. Respiratory capacity of Smaug1+2-knockdown U2O2 cells.  
(A) U2OS were treated with non-targeting (NT) siRNA or with siRNAs against both Smaug1 and Smaug2 
(siS1+S2) and respiration in intact cells (1 × 106 cells/mL) was examined in growth medium at 37 °C as 
described in Materials and Methods. Oxygen flow (pmol O2 × s−1 × 10−6 cells) and total oxygen concentration 
(nmol/mL) in the Oxygraph chamber are indicated as red and blue traces, respectively. CE: cellular substrate, 
P: Pyruvate, O: Oligomycin, U: Uncoupler (CCCP) R: Rotenone, A: Antimycin A. (B) After measuring routine 
oxygen consumption, the adenosine triphosphate (ATP)-synthase inhibitor oligomycin was added to evaluate 
proton LEAK. The uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP) allowed the measurement of 
maximal oxygen consumption (Max) stimulating maximal respiration assuming all required substrates are 
present. Finally, rotenone (complex I inhibitor) and antimycin A (complex III inhibitor), which completely prevent 
oxygen consumption through the electron respiratory chain were added. Oxygen flow per cells was corrected 
for ROX at the indicated mitochondrial respiration state. Calculated mitochondrial (mt) flux control ratios show 
basal cellular routine respiration (R), leak respiration (L) and fraction of respiration (netR = R-L) used for ATP 
production normalized to ETS capacity. 
 
Supplemental Figure 3. Mitochondrial network disruption upon Smaug1 and Smaug2 knockdown. 
U2OS cells were treated with the indicated siRNAs and live-stained with MitoTracker™ Red CMXRos. At least 
200 cells per treatment were analyzed and the percentage of cells with elongated mitochondria is indicated. A 
representative experiment out of three is shown. Scale bars, 10 μm. 
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